-transparent.png){kind=logo}
We report the successful management of a 25 year-old woman diagnosed in the second trimester of her pregnancy with chronic myelogenous leukemia (CML). She was treated with leukapheresis until her delivery at 38 weeks of gestation. The procedure was without significant adverse effects on the patient or the fetus. Following induced vaginal delivery, the patient underwent allogeneic bone marrow transplantation from her HLA-matched brother and is presently disease free 13 months following her transplant.
Related Publications
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
June 1986,
American journal of hematology,
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
January 1999,
Journal of clinical apheresis,
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
June 2015,
Gan to kagaku ryoho. Cancer & chemotherapy,
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
April 2004,
Japanese journal of clinical oncology,
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
January 2004,
Annals of hematology,
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
May 1977,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
January 2015,
Anticancer research,
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
May 1977,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
August 2020,
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
M S Bazarbashi, and
M R Smith, and
C Karanes, and
I Zielinski, and
C R Bishop
June 2012,
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
